These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 8852535)

  • 1. A "therapeutic window" with citalopram in a case of depression.
    Benazzi F
    Pharmacopsychiatry; 1996 Jan; 29(1):42. PubMed ID: 8852535
    [No Abstract]   [Full Text] [Related]  

  • 2. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Citalopram. An open study of a highly selective serotonin-uptake inhibitor administered by infusion to depressive patients].
    Charbonnier JF; Reboul P; Rougier M; Aubin B; Chassaing JL; Philippe P; Planche R; Hoepfner Petersen HE
    Encephale; 1987; 13(4):249-54. PubMed ID: 3311709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Open preliminary study of new antidepressive compound: citalopram].
    Ropert R; Lôo H; Gay C
    Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy: migraine and depression. Therapy with sumatripten and citalopram: perioperative anaesthesiological risk assessment].
    Ittner KP
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006; 41(7-8):464-5. PubMed ID: 16874568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Citalopram (Seropram) in tablet and infusion forms in the treatment of major depression].
    Svestka J; Cesková E; Kamenická V; Buresová A; Obrovská V; Synek O
    Cesk Psychiatr; 1993 Dec; 89(6):331-9. PubMed ID: 8124733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications for antidepressive medication].
    Soini M
    Duodecim; 1997; 113(3):255. PubMed ID: 11370036
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study.
    Robert P; Montgomery SA
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():29-35. PubMed ID: 7622809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome?
    Isbister GK; Dawson A; Whyte IM
    Can J Psychiatry; 2001 Sep; 46(7):657-9. PubMed ID: 11582830
    [No Abstract]   [Full Text] [Related]  

  • 10. Citalopram in mentally retarded patients with depression: a long-term clinical investigation.
    Verhoeven WM; Veendrik-Meekes MJ; Jacobs GA; van den Berg YW; Tuinier S
    Eur Psychiatry; 2001 Mar; 16(2):104-8. PubMed ID: 11311174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo onset of Parkinson's disease after antidepressant treatment with citalopram.
    Stadtland C; Erfurth A; Arolt V
    Pharmacopsychiatry; 2000 Sep; 33(5):194-5. PubMed ID: 11071022
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of elderly individuals with emotional disturbances: an open study with citalopram.
    Ragneskog H; Eriksson S; Karlsson I; Gottfries CG
    Int Psychogeriatr; 1996; 8(4):659-68. PubMed ID: 9147178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
    Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Citalopram and desmethylcitalopram for psychiatric patients].
    Linnet K; Olesen OV
    Ugeskr Laeger; 1996 Aug; 158(35):4920-3. PubMed ID: 8801700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy resistant major depression: improvement of symptomatology after combining antidepressants with Tianeptine (Stablon)].
    Niederhofer H
    Psychiatr Prax; 2003 May; 30(4):221-2. PubMed ID: 12768529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depression and cancer: therapeutic aspects].
    Gay C
    Encephale; 1998 Dec; 24 Spec No 2():72-80. PubMed ID: 9949931
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
    Schmauss M
    Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
    Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
    Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.